Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
ChemoCentryx (CCXI) Reports Positive Top-Line Rare Disease Data
11:17am, Tuesday, 22'nd Dec 2020
ChemoCentryx (CCXI) and Vifor Fresenius Medical Care Renal Pharma report positive top-line data from the study evaluating avacopan for the treatment of C3 Glomerulopathy.
MOUNTAIN VIEW, Calif. and ST. GALLEN, Switzerland, Dec. 21, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced topline data from the ACC
ChemoCentryx to Present at Two Upcoming Investor Conferences
08:30am, Thursday, 19'th Nov 2020
MOUNTAIN VIEW, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two up
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q3 2020 Results - Earnings Call Transcript
02:05am, Tuesday, 10'th Nov 2020
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q3 2020 Results - Earnings Call Transcript
ChemoCentryx Reports Third Quarter 2020 Financial Results and Recent Highlights
04:05pm, Monday, 09'th Nov 2020
-- New Drug Application (NDA ) accepted for review by U.S. Food and Drug Administration (FDA) for avacopan in ANCA -associated vasculitis with PDUFA goal date of July 7, 2021 -- -- Marketing Authoriza
-- Study Showed T reatment with Avacopan A chieved Statistical Superiority in Sustaining Remission at 52 Weeks and G reater I mprovement in R enal F unction C ompared to the Prednisone Group -- MOUNTA
ST. GALLEN, Switzerland and MOUNTAIN VIEW, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) Ltd. and ChemoCentryx, Inc., today announced that the European M
ChemoCentryx to Hold Third Quarter 2020 Financial Results Conference Call on Monday, November 9, 2020
08:30am, Monday, 02'nd Nov 2020
MOUNTAIN VIEW, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2020 financial results will be released after market close
-- Avacopan demonstrates statistically significant dose-dependent improvement in HiSCR (Hidradenitis Suppurativa Clinical Response) vs. placebo in pre-specified Hurley Stage III (severe HS) patients a
Stock Traders Purchase Large Volume of Call Options on ChemoCentryx (NASDAQ:CCXI)
02:00am, Sunday, 11'th Oct 2020
ChemoCentryx Inc (NASDAQ:CCXI) was the target of some unusual options trading on Friday. Investors purchased 3,359 call options on the company. This represents an increase of approximately 230% compar
Exane Derivatives Purchases 182 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
08:10am, Thursday, 08'th Oct 2020
Exane Derivatives boosted its stake in ChemoCentryx Inc (NASDAQ:CCXI) by 11.3% during the 3rd quarter, HoldingsChannel reports. The fund owned 1,794 shares of the biopharmaceutical company’s stock a
Principal Financial Group Inc. Buys 5,740 Shares of ChemoCentryx Inc (NASDAQ:CCXI)
07:26am, Thursday, 08'th Oct 2020
Principal Financial Group Inc. lifted its holdings in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 40.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 19,
ChemoCentryx Inc (NASDAQ:CCXI) Expected to Announce Quarterly Sales of $12.86 Million
06:20am, Friday, 02'nd Oct 2020
Analysts expect ChemoCentryx Inc (NASDAQ:CCXI) to report sales of $12.86 million for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for ChemoCentryx’s
7,600 Shares in ChemoCentryx Inc (NASDAQ:CCXI) Acquired by Handelsbanken Fonder AB
08:22am, Monday, 28'th Sep 2020
Handelsbanken Fonder AB bought a new position in shares of ChemoCentryx Inc (NASDAQ:CCXI) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
California State Teachers Retirement System Boosts Stock Holdings in ChemoCentryx Inc (NASDAQ:CCXI)
08:40am, Friday, 25'th Sep 2020
California State Teachers Retirement System lifted its stake in shares of ChemoCentryx Inc (NASDAQ:CCXI) by 8.3% during the second quarter, Holdings Channel reports. The fund owned 67,060 shares of th
